Wilson Sonsini Goodrich & Rosati provided IP and corporate counsel to DermBiont in the transaction.DermBiont announced its $35.2 million Series B financing. The financing was led by…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
